Neville Kukreja

Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes

Onuma Y, Muramatsu T, Girasis C, Kukreja N, Garcia-Garcia H, Daemen J, Gonzalo N, Piazza N, Eindhoven J, van Domburg R, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A154

Three-year clinical event rates in different age groups after contemporary percutaneous coronary intervention

Kukreja N, Onuma Y, Garcia-Garcia H, van Nierop J, Daemen J, van Domburg R, Serruys P

December 30, 2011 | 10.4244/EIJV7I8A153

The GuideLiner™ "child" catheter

Rao U, Gorog DA, Syzgula J, Kumar S, Stone C, Kukreja N

June 30, 2010 | 10.4244/EIJV6I2A44

Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts

Tyczynski P, Kukreja N, van Geuns R, Wykrzykowska JJ, Sheppard M, Di Mario C

May 25, 2010

Optical coherence tomography assessment of a new dedicated bifurcation stent

Tyczynski P, Ferrante G, Kukreja N, Moreno- Ambroj C, Barlis P, Ramasami N, de Silva R, Beatt K, Di Mario C

November 15, 2009 | 10.4244/EIJV5I5A89

Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents

Girasis C, Onuma Y, Wong C, Kukreja N, van Domburg R, Serruys P

June 30, 2009 | 10.4244/EIJV5I2A31

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.

Rodriguez A, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Granillo R, Rodríguez-Granillo G, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios I, Serruys P

June 30, 2009 | 10.4244/EIJV5I2A40

The CTTO registry: is the CT really necessary?

Di Mario C, Kukreja N

March 20, 2009

Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme

Onuma Y, Kukreja N, Ramcharitar S, Hochadel M, Gitt A, Serruys P

March 20, 2009

Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

Garcia-Garcia H, Gonzalo N, Pawar R, Kukreja N, Dudek D, Thuesen L, Ormiston J, Regar E, Serruys P

January 20, 2009

The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129)

Daemen J, van Twisk P-H, Kukreja N, van Domburg R, Boersma E, de Jaegere P, Serruys P

January 20, 2009

Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts

van Twisk P-H, Daemen J, Kukreja N, van Domburg R, Serruys P

November 20, 2008

Greyscale intravascular ultrasound and IVUS-radiofrequency tissue characterisation to improve understanding of the mechanisms of coronary stent thrombosis in drug-eluting stents

Garcia-Garcia H, Gonzalo N, Kukreja N, Alfonso F

August 20, 2008

Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study

Dani S, Kukreja N, Parikh P, Joshi H, Prajapati J, Jain S, Thanvi S, Shah B, Dutta J-P

May 13, 2008

Contemporary treatment of patients with chronic total occlusion: critical appraisal of different state-of-the-art techniques and devices

Garcia-Garcia H, Kukreja N, Daemen J, Tanimoto S, van Mieghem C, Gonzalo N, van Weenen S, van der Ent M, Sianos G, de Feyter P, Serruys P

August 20, 2007

Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents

Ramcharitar S, Garcia-Garcia H, Nakazawa G, Kukreja N, Ligthart J, Virmani R, Serruys P

August 20, 2007

MAHOROBA™: Tacrolimus eluting coronary stent

Tanimoto S, van der Giessen WJ, van Beusekom H, Sorop O, Kukreja N, Fukaya K, Nishide T, Nakano R, Maeda H, Serruys P

May 22, 2007

Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

Daemen J, Tsuchida K, Stefanini G, Vaina S, Kukreja N, de Jaegere P, Ong ATL, van Domburg R, Serruys P

November 20, 2006

Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis

Garcia-Garcia H, Goedhart D, Schuurbiers JCH, Kukreja N, Tanimoto S, Daemen J, Morel M, Bressers M, Van Es G-A, Wentzel J, Gijsen F, van der Steen A, Serruys P

November 20, 2006

Biodegradable drug eluting stents: invasive and non-invasive imaging

Kukreja N, Otsuka F, van Mieghem C, Ligthart J, Sianos G, Serruys P

November 20, 2006

Neville Kukreja

Latest news